Dr. Lukas D. Wartman, MD?
Update this Profile
Dr. Lukas D. Wartman, MD, Oncologist

Dr. Lukas D. Wartman, MD

Oncologist | Medical Oncology

660 S. Euclid Avenue campus box 8057 Saint Louis MO, 63110

About

Lukas D. Wartman, MD, is a top oncologist who lends his skills and expertise to serve patients at Siteman Cancer Center in St. Louis, Missouri. He is Assistant Director of the Cancer Genomics Section at The McDonnell Genome Institute and Assistant Professor within the Division of Oncology, Section of Stem Cell Biology at the Washington University School of Medicine in St. Louis, MO (2013-present). With ten years of experience as an oncologist and researcher, his areas of clinical interest include the treatment of acute and chronic leukemia in adults, blood cancer, bone marrow transplant, lymphoblastic leukemia, myelogenous leukemia, and lymphocytic leukemia.

Education and Training

University of Wisconsin Bachelor of Science in Molecular Biology 1998

Washington University School of Medicine Medical 2005

Board Certification

American Board of Internal Medicine

Provider Details

Male English

Faculty Titles & Positions

  • Assistant Professor within the Division of Oncology, Section of Stem Cell Biology Washington University School of Medicine 2013 -
  • Assistant Director of the Cancer Genomics Section The McDonnell Genome Institute - Present

Awards

  • Albert F. Koetter, MD Distinguished Student Scholarship 1999  
  • Albert F. Koetter, MD Distinguished Student Scholarship 2000  
  • Alpha Omega Alpha 2002  
  • McGraw-Hill and Appleton and Lange Medical Publications Student Award 2002  
  • Lee B. & Virginia G. Harrison Memorial Scholar 2002  
  • The Park J. White Prize in Medical Ethics 2003  
  • Knowlton Award for Clinical Excellence 2009  
  • Fellows’ Award from Mayo Clinic Hematology/Oncology Review 2010  
  • National Institutes of Health Loan Repayment Program Award 2010  
  • National Institutes of Health Loan Repayment Program Award 2011  
  • National Institutes of Health Loan Repayment Program Award 2012  
  • Albert F. Koetter, MD Distinguished Student Scholarship Year  

Treatments

  • Acute Myeloid Leukemia (aml)
  • Lymphoma
  • Multiple Myeloma
  • Leukemia
  • Dermal Aesthetics
  • Extra Corporeal Shockwave Therapy

Professional Memberships

  • Member of the American Society of Hematology  
  • Member of the American Society of Clinical Oncology  
  • Member of the American Society of Blood and Marrow Transplantation  

Residency

  • Barnes-Jewish Hospital Internal Medicine  2007
  • Barnes-Jewish Hospital 2007 Internal Medicine

Fellowships

  • Washington University School of Medicine Oncology  2011

Fellowships

  • Washington University School of Medicine2011Oncology

Professional Society Memberships

  • Member of the American Society of Hematology Member of the American Society of Clinical Oncology Member of the American Society of Blood and Marrow Transplantation

Dr. Lukas D. Wartman, MD's Practice location

Siteman Cancer Center at Washington University

660 S. Euclid Avenue campus box 8057 -
Saint Louis, MO 63110
Get Direction
New patients: 314-747-1171, 314-747-1171

Request An Appointment With Dr. Lukas D. Wartman, MD | Oncologist | Medical Oncology

Please note that this request is not considered final until you receive email notification confirming the details.

In the event the doctor is not yet registered with FindaTopDoc, we will contact the office on your behalf in an effort to secure your appointment.

Dr. Lukas D. Wartman, MD's reviews

(0)
Write Review

Media Releases

Get to know Oncologist Dr. Lukas D. Wartman, who serves patients in St. Louis, Missouri.

Dr. Wartman is a well-versed oncologist whose areas of clinical interest include the treatment of acute and chronic leukemia in adults, blood cancer, bone marrow transplant, lymphoblastic leukemia, myelogenous leukemia, and lymphocytic leukemia. Being a leukemia survivor himself, he is involved in making clinical sequencing available for cancer patients treated at the Siteman Cancer Center.

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is a cancer treatment, research, and education institution with six locations in the St. Louis area. It is the only cancer center in Missouri to hold the prestigious Comprehensive Cancer Center designation and “Exceptional” rating from the National Cancer Institute and membership in the National Comprehensive Cancer Network. Its mission is to prevent cancer in the community and transform cancer patient care through scientific discovery.

Alongside his clinical role, Dr. Wartman has been serving as an Assistant Professor within the Division of Oncology, Section of Stem Cell Biology at the Washington University School of Medicine in St. Louis since 2013.

Among the doctor’s research efforts, he led the study that sequenced the first mouse model of human cancer (a mouse model of APL developed in Timothy Ley’s Lab). He recently started his own lab, which is extending the findings from that study to more than 100 banked tumors from the same model. He is studying the role of loss of function mutations in KDM6A, a histone H3K27 demethylase, in the role of AML and cancer pathogenesis. He is also an active member of The McDonnell Genome Institute at Washington University where he serves as Assistant Director of the Cancer Genomics Section. In this regard, his research interest is in using ChIP-Seq to define epigenetic changes in cancer. 

Following the completion of his Bachelor of Science degree in Molecular Biology from the University of Wisconsin in 1998, Dr. Wartman went on to obtain his medical degree from the Washington University School of Medicine in St. Louis in 2005. He completed his residency in internal medicine at Barnes-Jewish Hospital in 2007, followed by his fellowships in oncology at the Washington University School of Medicine in St. Louis in 2011. 

In order to stay up to date in his field, he remains a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society of Blood and Marrow Transplantation.

Furthermore, he is board-certified in internal medicine and medical oncology by the American Board of Internal Medicine, a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. They lead a cancer treatment team of various healthcare professionals, treat patients with radiation therapy, coordinate treatment plans and prescribe various types of treatment, including chemotherapy and immunotherapy, as well as assist patients with pain management.

As a testament to his success, Dr. Wartman is the recipient of numerous awards and honors, including Albert F. Koetter, MD Distinguished Student Scholarship (1999-2003), Alpha Omega Alpha (2002), McGraw-Hill and Appleton and Lange Medical Publications Student Award (2002), Lee B. & Virginia G. Harrison Memorial Scholar (2002), The Park J. White Prize in Medical Ethics (2003), Knowlton Award for Clinical Excellence (2009), Fellows’ Award from Mayo Clinic Hematology/Oncology Review (2010), and National Institutes of Health Loan Repayment Program Award (2010-2012).

Additional Information

Lukas D. Wartman, MD, is a Top Bone Marrow Transplant Specialist and Medical Oncologist with Siteman Cancer Center in St. Louis, Missouri

 

Lukas D. Wartman, MD, is a top oncologist who lends his skills and expertise to serve patients at Siteman Cancer Center in St. Louis, Missouri. He is Assistant Director of the Cancer Genomics Section at The McDonnell Genome Institute and Assistant Professor within the Division of Oncology, Section of Stem Cell Biology at the Washington University School of Medicine in St. Louis, MO (2013-present). With ten years of experience as an oncologist and researcher, his areas of clinical interest include the treatment of acute and chronic leukemia in adults, blood cancer, bone marrow transplant, lymphoblastic leukemia, myelogenous leukemia, and lymphocytic leukemia. Dr. Wartman is a leukemia survivor himself, and is, therefore, actively involved in making clinical sequencing available for cancer patients treated at the Siteman Cancer Center. Research interests include leukemogenesis, acute promeylocytic leukemia, cancer genomics, and epigenetics. For more information about Dr. Wartman, please visit https://oncology.wustl.edu/people/faculty/Wartman/Wartman_Res.html.

Lukas D. Wartman, MD, is a 2005-graduate of the Washington University School of Medicine in St. Louis, MO. His postgraduate training includes his residency in internal medicine at Barnes-Jewish Hospital (2005-2007), as well as his clinical fellowship in hematology-oncology (2007-2008) and his research fellowship in stem cell biology (2008-2011) performed at the Washington University School of Medicine in St. Louis, MO. Dr. Wartman completed his undergraduate education, i.e., his Bachelor of Science degree in Molecular Biology, at the University of Wisconsin in 1998. He attained board certification in internal medicine and medical oncology with the American Board of Internal Medicine. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society of Blood and Marrow Transplantation. For more information about Lukas D. Wartman, MD, please visit https://www.findatopdoc.com/doctor/2198551-Lukas-Wartman-Oncologist.

Lukas D. Wartman, MD, is the recipient of the Albert F. Koetter MD Distinguished Student Scholarship (1999-2003), Alpha Omega Alpha Induction (2002), McGraw-Hill and Appleton and Lange Medical Publications Student Award (2002), Lee B. & Virginia G. Harrison Memorial Scholarship (2002), The Park J. White Prize in Medical Ethics (2003), Knowlton Award for Clinical Excellence (2009), Fellows’ Award from Mayo Clinic Hematology/Oncology Review (2010), and National Institutes of Health Loan Repayment Program Award (2010-2012). As per Siteman Cancer Center’s website, “Dr. Wartman led the study that sequenced the first mouse model of human cancer (a mouse model of leukemia developed in Dr. Timothy Ley’s Laboratory). He recently started his own lab and is studying the role of loss of function mutations in Kdm6a, a histone H3K27 demethylase, in cancer pathogenesis. He also collaborates with investigators at The Genome Institute to organize a monthly Genomics Tumor Board.” For more information about Lukas D. Wartman, MD, please visit https://siteman.wustl.edu/doctor/wartman-lukas-md/.

Recommended Articles

  • Nodular Melanoma Symptoms

    What is nodular melanoma?Nodular melanoma is one of the five subgroups of melanoma. It usually develops in the cells of the skin that produce the pigment called melanin, which gives the skin its color. Approximately 15 percent of melanoma cases are nodular melanoma and is the most aggressive...

  • What are the Different Types of Breast Cancer?

    Appropriate treatment options for breast cancer differ depending on what type of cancer the individual has. A biopsy of the tissue samples from the breast helps to identify the type of breast cancer. Most breast cancers bloom in the ducts that connect lobules to the nipple in the breast. It is rare...

  • The Link Between Ovarian Cancer Survival and Pregnancy

    For women who have survived cancer, their bodies have inevitably been through a lot. Therefore, it is not entirely unsurprising, but it is dismaying, that they are one-third less likely to be able to achieve pregnancy than other women. This statistic was taken from the first study to actually...

  • What is Large Cell Carcinoma?

    Large cell carcinoma, is a kind of lung cancer, is classified as Non-small cell lung cancer (NSCLC), and prevails in 80-85% of people who have lung cancer. This is compared to small cell lung cancer, which affects 10-15% of people.In large cell carcinoma, there will be an abnormal growth in the size...

  • Are There Routine Checks for Ovarian Cancer?

    Ovarian cancer is the most common cause of death among gynecologic types of cancer. The most common risk factors for ovarian cancer are:...

  • Financially Managing Lymphoma Care

    If you are living with lymphoma, one of your main concerns may be the payment charges that seem to be piling up too quickly. It can be stressful enough living with cancer, let alone having to worry about going into debt. For this reason, it is important to become aware of the different expenses...

Nearby Providers

Nearest Hospitals

BARNES JEWISH HOSPITALl

ONE BARNES-JEWISH HOSPITAL PLAZA SAINT LOUIS MO 63110

Head north on South Euclid Avenue 184 ft
Turn left onto Barnes Hospital Plaza 474 ft
You have arrived at your destination, on the right

ST LOUIS CHILDRENS HOSPITALl

ONE CHILDRENS PLACE SAINT LOUIS MO 63110

Head north on South Euclid Avenue 184 ft
Turn left onto Barnes Hospital Plaza 892 ft
Turn right onto North Kingshighway Boulevard 838 ft
Turn right onto Childrens Place 424 ft
Continue slightly left onto Childrens Place 74 ft
You have arrived at your destination, on the right

SHRINERS HOSPITALS FOR CHILDRENl

4400 CLAYTON AVE SAINT LOUIS MO 63110

Head south on South Euclid Avenue 443 ft
Turn left onto Clayton Avenue 1561 ft
You have arrived at your destination, on the right